LGM
Logos Global Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2M | Buy |
+600,000
| New | +$12.2M | 1.35% | 22 |
|
|
2024
Q4 | – | Sell |
-900,000
| Closed | -$30.6M | – | 52 |
|
|
2024
Q3 | $30.6M | Buy |
+900,000
| New | +$30.6M | 3.3% | 9 |
|
|
2024
Q2 | – | Sell |
-650,000
| Closed | -$27.3M | – | 55 |
|
|
2024
Q1 | $27.3M | Buy |
+650,000
| New | +$27.3M | 2.21% | 13 |
|
|
2020
Q4 | – | Sell |
-1,200,000
| Closed | -$17.8M | – | 59 |
|
|
2020
Q3 | $17.8M | Sell |
1,200,000
-800,000
| -40% | -$11.9M | 2.28% | 13 |
|
|
2020
Q2 | $26M | Buy |
+2,000,000
| New | +$26M | 5.2% | 3 |
|